News

NIDA-Funded Research with UC

Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction

SAN DIEGO, Calif. – May 10, 2022Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction. 

Read More

Oregon: Increase in Fentanyl Use

Oregon Experiencing Substantial Increase in Fentanyl Use for 2022

SAN DIEGO, Calif. – May 4, 2022 – A dramatic increase in drug overdose deaths, primarily due to illicit fentanyl, is being reported across the U.S.1 Contributing to these deaths is the proliferation of counterfeit pills often containing fentanyl that are nearly impossible to distinguish from authentic medications.2

Read More

Dr. Passik | BOD for IHFDA

Millennium Health VP, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD Appointed to Board of Directors for International Health Facility Diversion Association

SAN DIEGO, Calif. – March 29, 2022 – The International Health Facility Diversion Association (IHFDA) has tapped the expertise of Millennium Health’s Vice President, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD for its Board of Directors. Read More

Signals Report Volume 4

Millennium Health Signals Report™ Volume 4 Highlights Substantial Changes in Illicit Drug Use Trends

Report Provides Recent Findings Regarding Known Contributors to Drug Overdose Deaths

SAN DIEGO, Calif. – February 9, 2022 – Drug overdose deaths in the U.S. are the highest ever recorded and are primarily driven by illicit fentanyl and methamphetamine.1Read More

2021 Clinical Recap

SAN DIEGO, Calif. – January 19, 2022 – Celebrating the New Year with a look back at some of our important work from 2021. Many exciting things to come in 2022!Read More

Welcome CEO Scott Walton

Millennium Health Appoints Scott Walton as Chief Executive Officer

SAN DIEGO, Calif. – October 26, 2021 – Millennium Health, a national leader in specialty medication monitoring and drug testing, today announced the appointment of Scott Walton as Chief Executive Officer (CEO) effective immediately.Read More

Alcohol Study

Millennium Health Study Published in Drug and Alcohol Dependence Highlights COVID-19, Seasonal and Regional Influences on Alcohol Consumption

SAN DIEGO, Calif. – October 5, 2021 – According to the Centers for Disease Control and Prevention (CDC), excessive alcohol use remains the leading cause of preventable death in the U.S., with over 95,000 deaths every year due to alcohol-related causes.1 Read More

Dr. Passik Joins the Team

Distinguished Psychologist and Addiction Specialist Joins Millennium Health Management Team

SAN DIEGO, Calif. – September 22, 2021 – Specialty medication monitoring and drug testing company, Millennium Health today announced leading pain and addiction expert, Steven D. Passik, PhD has joined its management team as VP, Scientific Affairs and Head of Clinical Data Programs. Dr. Passik will focus primarily on expanding work begun at Millennium Health to inform clinicians, policy makers and public health officials about the changing landscape of substance abuse to help facilitate a data driven approach to this enormous public health problem.

Read More

Buprenorphine Study in JAMA

Millennium Health Publication in JAMA Network Open Highlights Drug Use Trends in Patients Treated with Buprenorphine for Opioid Use Disorder

SAN DIEGO, Calif. – September 14, 2021 – A JAMA Network Open study, led by Brendan Saloner, PhD, Associate Professor with Johns Hopkins Bloomberg School of Public Health, and co-authored by Millennium Health researchers, highlights the role of buprenorphine as a critically important medication for reducing harmful opioid use.

Read More

Columbia University Agreement

Columbia University and Millennium Health Join Forces to Combat Overdoses in New York

SAN DIEGO, Calif. – August 31, 2021Millennium Health, a leader in delivering clinical drug testing services to health care providers, has entered into an agreement with Columbia University to provide valuable, real-time drug use trends data through our Emerging Threat Intelligence (ETI) Program™ to aid their efforts with the HEALing Communities Study (HCS) in New York.

Read More